Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Research Council (Starting grant 716509) to D.A. Pijnappels Background Recently it was demonstrated how the heart itself could be enabled to quickly restore its rhythm by realizing a biologically-integrated cardiac defibrillator (BioICD) through modification and subsequent expression of ion channels in cardiomyocytes [1]. By incorporating these frequency-dependent depolarizing ion channels, abnormal cardiac rhythm could be rapidly detected and terminated to restore sinus rhythm in a fully biological and shock-free manner. However, from a translational point of view, it remains unclear how such rhythm restoration can be realized via ion channel gene therapy. Purpose To explore and understand the importance of the distribution and number of BioICD-expressing cardiomyocytes in realizing fully biological restoration of cardiac rhythm. Methods To this purpose, two different realistic gene therapy configurations, i.e. those corresponding to systemic and local transgene delivery, were tested in a digital twin of human ventricular cardiac monolayers. In the systemic delivery group, BioICD-expressing cells were uniformly distributed over the tissue at different total expression percentages. In the local delivery group, circular areas were populated with BioICD-expressing cells, randomly arranged in a Gaussian distribution. Spiral waves were initiated in both groups and studied for 10 seconds. An additional set of simulations for the systemic delivery group involved an adapted BioICD ion channel with a slower opening and faster closing rate. Results Upon comparing both gene therapy methods, the systemic approach showed a gradually increasing arrhythmia termination chance with increasing BioICD-expression percentage, while local delivery did not result in termination. Instead, local delivery resulted in islands of ionic heterogeneity, causing attraction and anchoring of the spiral waves in a size and distance-dependent manner. Building on the results of the systemic approach, different ion channel parameters were tried, which resulted in normal rhythm being restored in all cases for >50% BioICD expressing cells. Time till termination was inversely related to the percentage, resulting in only 4.3s and 2.5s for 50% and 100%, respectively. Regarding termination, it was observed that conduction blocks appeared throughout the tissue and subsequently connected to force arrhythmic waves to terminate, while this process remained incomplete in the <50% groups. Conclusion This study reveals that wide-spread distribution of BioICD-expressing cardiomyocytes is required for the realization of fully biological self-restoration of cardiac rhythm, of which the efficiency is ion-channel-dynamics- and dosage-dependent. Local expression, however, results in stabilization of spiral wave activity. Further exploration of this emerging concept of biological cardioversion may not only expand our understanding of cardiac arrhythmias, but also pave the way to breakthrough advances in arrhythmia management.

Sonogenetics is a novel antiarrhythmic treatment

A theoretic model for sonogenetic antiarrhythmia

In Vitro Assessing the Risk of Drug-Induced Cardiotoxicity by Embryonic Stem Cell-Based Biosensor

Recent advancement of sonogenetics: A promising noninvasive cellular manipulation by ultrasound

Sonogenetics in the Treatment of Chronic Diseases: A New Method for Cell Regulation

Ultrasonic Neuromodulation and Sonogenetics: A New Era for Neural Modulation

Graphene Biointerface for Cardiac Arrhythmia Diagnosis and Treatment

The principles and promising future of sonogenetics for precision medicine

Airy-beam holographic sonogenetics for advancing neuromodulation precision and flexibility

Gene and stem cell therapy for inherited cardiac arrhythmias

Fully Implantable Wireless Cardiac Pacing and Sensing System Integrated with Hydrogel Electrodes

Sonothermogenetics for noninvasive and cell-type specific deep brain neuromodulation

Modulation of deep neural circuits with sonogenetics

Insights into the prospects of nanobiomaterials in the treatment of cardiac arrhythmia

Exploring translational approaches for fully biological cardiac rhythm restoration through ion channel gene therapy

Mitochondria-targeted sonodynamic modulation of neuroinflammation to protect against myocardial ischemia‒reperfusion injury

Sonogenetic modulation of cellular activities using an engineered auditory-sensing protein

Hybrid nanogenerator based closed-loop self-powered low-level vagus nerve stimulation system for atrial fibrillation treatment

Thermogenetics for cardiac pacing

Optical Control of Cardiac Electrophysiology by the Photochromic Ligand AB2

In situ assembly of an injectable cardiac stimulator